Metraipolis › archive › dc_7cda21ecc63c
Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42405441
- DOI
- 10.1111/ene.70698
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T12:25:43.886Z
- SHA-256 of the archived text
cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8- Stable URL of this page
https://metraipolis.com/documento/dc_7cda21ecc63c
How to cite
Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441 — Europe PMC (en), https://europepmc.org/article/MED/42405441 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cda21ecc63c (Metraipolis archive dc_7cda21ecc63c, sha256 cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8)
BibTeX
@misc{dc7cda21ecc63c,
title = {Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42405441},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cda21ecc63c; sha256 cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42405441. Agents can read the archived copy with the MCP tool read_document.